ROPES WEALTH ADVISORS LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 276 filers reported holding GW PHARMACEUTICALS PLC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROPES WEALTH ADVISORS LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$29,000
+20.8%
2490.0%0.00%
-20.0%
Q3 2020$24,000
-22.6%
2490.0%0.01%
-16.7%
Q2 2020$31,000
+40.9%
2490.0%0.01%0.0%
Q1 2020$22,000
-15.4%
2490.0%0.01%0.0%
Q4 2019$26,000
-10.3%
2490.0%0.01%0.0%
Q3 2019$29,000
-19.4%
249
+19.1%
0.01%
-25.0%
Q2 2019$36,000
+2.9%
2090.0%0.01%
-11.1%
Q1 2019$35,000
+75.0%
2090.0%0.01%
+50.0%
Q4 2018$20,000
+66.7%
209
+202.9%
0.01%
+100.0%
Q3 2018$12,000690.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders